David Beyer


David is a Partner at Amplify Partners and focuses on machine learning and analytics startups, as well as new ventures in cloud infrastructure.

Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He was subsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies.

David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Caribou Biosciences, Airtable, Ginkgo Bioworks, Function of Beauty, Cruise Automation, Astranis, Bugcrowd, and Rigetti Computing. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.

Fun facts about his childhood

David first started playing ice hockey at the age of six in what is known as the ice hockey capital of the world — Tel Aviv. He somehow survived, despite playing with Russian immigrants twice his age and three times his size. David also received his first piece of gum from Carl Sagan, or that’s at least what his parents tell him.

Places he’s lived before Silicon Valley

Hattiesburg, MS; Tel Aviv, Israel; Andover, MA; St. Petersburg, Russia; Chevy Chase, MD